Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Bevacizumab-based Chemotherapy in Advanced Gastric Cancer
NCT00952003Phase 2Completed
- Sponsor
- Arbeitsgemeinschaft medikamentoese Tumortherapie
- Start
- Jul 2009
- Primary completion
- Oct 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in gastric cancer (GC), sponsored by Arbeitsgemeinschaft medikamentoese Tumortherapie. Started Jul 2009; status: completed.
02
Drugs
bevacizumab
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00952003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00952003.